Specially, GLUT1 is overexpressed in brain capillary endothelial cells and glioblastoma, therefore, nanocarriers can be designed to target GLUT1 for improved BBB penetration and glioblastoma accumulation. This evidence concerns the gene SLC2A1 and glioblastoma.